NCT00398463View on ClinicalTrials.gov

Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance

PHASE4CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

May 31, 2011

Conditions
Angioplasty, Transluminal, Percutaneous Coronary
Interventions
DRUG

Tirofiban

Tirofiban infusion given as high bolus dose plus standard 14-24 hour infusion

DRUG

Placebo

Saline infusion will be administered for 14-24 hours

Trial Locations (1)

44100

Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara, Ferrara

All Listed Sponsors
lead

Università degli Studi di Ferrara

OTHER

NCT00398463 - Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance | Biotech Hunter | Biotech Hunter